Page last updated: 2024-10-31

clorgyline and Diabetes Mellitus, Type 2

clorgyline has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsumoto, T1
Watanabe, S1
Taguchi, K1
Kobayashi, T1

Other Studies

1 other study available for clorgyline and Diabetes Mellitus, Type 2

ArticleYear
Mechanisms underlying increased serotonin-induced contraction in carotid arteries from chronic type 2 diabetic Goto-Kakizaki rats.
    Pharmacological research, 2014, Volume: 87

    Topics: Animals; Carotid Arteries; Clorgyline; Diabetes Mellitus, Type 2; Disease Models, Animal; In Vitro T

2014